314 related articles for article (PubMed ID: 33207822)
1. Osteoprotective Roles of Green Tea Catechins.
Huang HT; Cheng TL; Lin SY; Ho CJ; Chyu JY; Yang RS; Chen CH; Shen CL
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33207822
[TBL] [Abstract][Full Text] [Related]
2. Functions and mechanisms of green tea catechins in regulating bone remodeling.
Shen CL; Kwun IS; Wang S; Mo H; Chen L; Jenkins M; Brackee G; Chen CH; Chyu MC
Curr Drug Targets; 2013 Dec; 14(13):1619-30. PubMed ID: 24041336
[TBL] [Abstract][Full Text] [Related]
3. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
4. Osteogenic mechanism of chlorogenic acid and its application in clinical practice.
Shen J; Zhang S; Zhang J; Wei X; Wang Z; Han B
Front Pharmacol; 2024; 15():1396354. PubMed ID: 38873428
[TBL] [Abstract][Full Text] [Related]
5. Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Kim JL; Kang SW; Kang MK; Gong JH; Lee ES; Han SJ; Kang YH
J Cell Biochem; 2012 Jan; 113(1):247-59. PubMed ID: 21898547
[TBL] [Abstract][Full Text] [Related]
6. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-20 differentially regulates bone mesenchymal stem cell activities in RANKL-induced osteoclastogenesis through the OPG/RANKL/RANK axis and the NF-κB, MAPK and AKT signalling pathways.
Meng B; Wu D; Cheng Y; Huang P; Liu Y; Gan L; Liu C; Cao Y
Scand J Immunol; 2020 May; 91(5):e12874. PubMed ID: 32090353
[TBL] [Abstract][Full Text] [Related]
8. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
9. Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.
Li X; Wang Y; Li L; Zhou S; Zhao F
Cell Biol Toxicol; 2021 Dec; 37(6):849-871. PubMed ID: 33423118
[TBL] [Abstract][Full Text] [Related]
10. Kefir peptides ameliorate osteoporosis in AKR1A1 knockout mice with vitamin C deficiency by promoting osteoblastogenesis and inhibiting osteoclastogenesis.
Chang GR; Lin WY; Fan HC; Tu MY; Liu YH; Yen CC; Cidem A; Chen W; Chen CM
Biomed Pharmacother; 2022 Dec; 156():113859. PubMed ID: 36252352
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin.
Chen ST; Kang L; Wang CZ; Huang PJ; Huang HT; Lin SY; Chou SH; Lu CC; Shen PC; Lin YS; Chen CH
Molecules; 2019 Jan; 24(1):. PubMed ID: 30609798
[TBL] [Abstract][Full Text] [Related]
12. Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.
Lee DW; Kwon JY; Kim HK; Lee HJ; Kim ES; Kim HJ; Kim HJ; Lee HB
Int J Med Sci; 2018; 15(7):723-729. PubMed ID: 29910677
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
[TBL] [Abstract][Full Text] [Related]
14. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
15.
Ma Z; Tang X; Chen Y; Wang H; Li Y; Long Y; Liu R
Oxid Med Cell Longev; 2023; 2023():7212642. PubMed ID: 36760348
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing NF-κB and MAPK signaling pathways.
Xu H; Liu T; Jia Y; Li J; Jiang L; Hu C; Wang X; Sheng J
Int Immunopharmacol; 2021 Jun; 95():107464. PubMed ID: 33677256
[TBL] [Abstract][Full Text] [Related]
17. Biological effects of melatonin on osteoblast/osteoclast cocultures, bone, and quality of life: Implications of a role for MT2 melatonin receptors, MEK1/2, and MEK5 in melatonin-mediated osteoblastogenesis.
Maria S; Samsonraj RM; Munmun F; Glas J; Silvestros M; Kotlarczyk MP; Rylands R; Dudakovic A; van Wijnen AJ; Enderby LT; Lassila H; Dodda B; Davis VL; Balk J; Burow M; Bunnell BA; Witt-Enderby PA
J Pineal Res; 2018 Apr; 64(3):. PubMed ID: 29285799
[TBL] [Abstract][Full Text] [Related]
18. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.
Yamaguchi M; Weitzmann MN; Murata T
Mol Cell Biochem; 2012 Jan; 359(1-2):193-203. PubMed ID: 21842421
[TBL] [Abstract][Full Text] [Related]
19. The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis.
Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
Osteoporos Int; 2013 May; 24(5):1647-61. PubMed ID: 23104199
[TBL] [Abstract][Full Text] [Related]
20. miR-99a in bone homeostasis: Regulating osteogenic lineage commitment and osteoclast differentiation.
Moura SR; Bras JP; Freitas J; Osório H; Barbosa MA; Santos SG; Almeida MI
Bone; 2020 May; 134():115303. PubMed ID: 32126314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
